A Prospective, Multicenter, Randomized, Controlled Clinical Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

Trial ID:
IRB-13-6282
Quang Nguyen
The objective of this study is to demonstrate the ability of the Hydrus Implant to lower intraocular pressure in glaucoma patients undergoing cataract surgery.

Inclusion Criteria:

  • Diagnosis of Primary Open Angle Glaucoma or Pseudoexfoliative Glaucoma.
  • Operable, age-related cataract eligible for phacoemulsification.

Exclusion Criteria:

  • Closed Angle and narrow angle forms of Glaucoma.
  • Other Secondary Glaucoma, (such as neovascular, uveitic, traumatic, steroid induced, lens induced); glaucoma associated with increase episcleral venous pressure; congenital or developmental glaucoma.